fda compounding glp-1 enforcement news today 2025 november semaglutide The FDA has released new guidance for providers prescribing GLP-1 Shortage = Over New project announcement: HHS‑OIG is

(Keep in mind this is much higher than the approved dosage strengths.) The Wegovy pill reduced blood sugar levels to a normal level for 71% of people with prediabetes , compared to only 33% of people taking a placebo

HC: Formal Analysis, Investigation, Writingreview and editing

Liposomal formulations improve bioavailability marginally (perhaps 2535% vs 2030% for standard oral forms), but they cost 34 more

Mirabile M.D

Its been overdue and much needed. Why Medicare Doesnt Cover Weight Loss Drugs Right now, Medicare covers GLP-1 drugs under Part D only for conditions such as cardiovascular disease, type 2 diabetes, or sleep apneanot for weight loss alone